Page 47 - 80_01
P. 47
Elvira
López--Oliva
Muñoz,
Emilia
Muñoz
Martínez
157. Glass,
C.K.,
Rosenfeld,
M.G.,
2000.
The
coregulator
exchange
in
transcriptional
functions
of
nuclear
receptors.
Genes
Dev
14,
121--141.
158.
Lee,
S.,
Lee,
J.,
Lee,
S.K.,
Lee,
J.W.,
2008.
Activating
signal
cointegrator--2
is
an
essential
adaptor
to
recruit
histone
H3
lysine
4
methyltransferases
MLL3
and
MLL4
to
the
liver
X
receptors.
Mol
Endocrinol
22,
1312--1319.
159. Jakobsson,
T.,
Venteclef,
N.,
Toresson,
G.
y
col.
2009.
GPS2
is
required
for
cholesterol
efflux
by
triggering
histone
demethylation,
LXR
recruitment,
and
coregulator
assembly
at
the
ABCG1
locus.
Mol
Cell
34,
510--518.
160. Venteclef,
N.,
Jakobsson,
T.,
Ehrlund,
A.
y
col.
2010.
GPS2--dependent
corepressor/SUMO
pathways
govern
anti--inflammatory
actions
of
LRH--1
and
LXRbeta
in
the
hepatic
acute
phase
response.
Genes
Dev
24,
381--395.
161. Lehmann,
J.M.,
Kliewer,
S.A.,
Moore,
L.B.
y
col.
1997.
Activation
of
the
nuclear
receptor
LXR
by
oxysterols
defines
a
new
hormone
response
pathway.
J
Biol
Chem
272,
3137--3140.
162. Li,
X.,
Yeh,
V.,
Molteni,
V.,
2010.
Liver
X
receptor
modulators:
a
review
of
recently
patented
compounds
(2007--
2009).
Expert
Opin
Ther
Pat
20,
535--562.
163. Ou,
J.,
Tu,
H.,
Shan,
B.
y
col.
2001.
Unsaturated
fatty
acids
inhibit
transcription
of
the
sterol
regulatory
element--binding
protein--1c
(SREBP--1c)
gene
by
antagonizing
ligand--
dependent
activation
of
the
LXR.
Proc
Natl
Acad
Sci
U
S
A
98,
6027--6032.
164. Oberkofler,
H.,
Schraml,
E.,
Krempler,
F.,
Patsch,
W.,
2003.
Potentiation
of
liver
X
receptor
transcriptional
activity
by
peroxisome--proliferator--activated
receptor
gamma
co--
activator
1
alpha.
Biochem
J
371,
89--96.
165. Li,
X.,
Zhang,
S.,
Blander,
G.
y
col.
2007.
SIRT1
deacetylates
and
positively
regulates
the
nuclear
receptor
LXR.
Mol
Cell
28,
91--106.
166. Yamamoto,
T.,
Shimano,
H.,
Inoue,
N.
y
col.2007.
Protein
kinase
A
suppresses
sterol
regulatory
element--binding
protein--1C
expression
via
phosphorylation
of
liver
X
receptor
in
the
liver.
J
Biol
Chem
282,
11687--11695.
167. Tobin,
K.A.,
Ulven,
S.M.,
Schuster,
G.U.
y
col.
2002.
Liver
X
receptors
as
insulin--
mediating
factors
in
fatty
acid
and
cholesterol
biosynthesis.
J
Biol
Chem
277,
10691--
10697.
168. Liu,
X.,
Qiao,
A.,
Ke,
Y.
y
col.
2010.
FoxO1
represses
LXRa--mediated
transcriptional
activity
of
SREBP--1c
promoter
in
HepG2
cells.
FEBS
Lett
584,
4330--4334.
169. Chinetti,
G.,
Lestavel,
S.,
Bocher,
V.
y
col.
2001.
PPAR--alpha
and
PPAR--gamma
activators
induce
cholesterol
removal
from
human
macrophage
foam
cells
through
stimulation
of
the
ABCA1
pathway.
Nat
Med
7,
53--58.
170. Brendel,
C.,
Schoonjans,
K.,
Botrugno,
O.A.
y
col.
2002.
The
small
heterodimer
partner
interacts
with
the
liver
X
receptor
alpha
and
represses
its
transcriptional
activity.
Mol
Endocrinol
16,
2065--2076.
171. Kalaany,
N.Y.,
Gauthier,
K.C.,
Zavacki,
A.M.
y
col.
2005.
LXRs
regulate
the
balance
between
fat
storage
and
oxidation.
Cell
Metab
1,
231--244.
172. Repa,
J.J.,
Turley,
S.D.,
Lobaccaro,
J.A.
y
col.
2000.
Regulation
of
absorption
and
ABC1--mediated
efflux
of
cholesterol
by
RXR
heterodimers.
Science
289,
1524--1529.
173. Brunham,
L.R.,
Kruit,
J.K.,
Pape,
T.D.
y
col.
2006.
Tissue--specific
induction
of
intestinal
ABCA1
expression
with
a
liver
X
receptor
agonist
raises
plasma
HDL
cholesterol
levels.
Circ
Res
99,
672--674.
174. Feig,
J.E.,
Pineda--Torra,
I.,
Sanson,
M.
y
col.
2010.
LXR
promotes
the
maximal
egress
of
monocyte--derived
cells
from
mouse
aortic
plaques
during
atherosclerosis
regression.
J
Clin
Invest
120,
4415--4424.
175. Cao,
G.,
Liang,
Y.,
Broderick,
C.L.
y
col.
2003.
Antidiabetic
action
of
a
liver
x
receptor
agonist
mediated
by
inhibition
of
hepatic
gluconeogenesis.
J
Biol
Chem
278,
1131--1136.
176. Grefhorst,
A.,
van
Dijk,
T.H.,
Hammer,
A.
y
col.
2005.
Differential
effects
of
pharmacological
liver
X
receptor
activation
on
hepatic
and
peripheral
insulin
sensitivity
in
lean
and
ob/ob
mice.
Am
J
Physiol
Endocrinol
Metab
289,
E829--838.
177. Laffitte,
B.A.,
Chao,
L.C.,
Li,
J.
y
col.
2003.
Activation
of
liver
X
receptor
improves
glucose
tolerance
through
coordinate
regulation
of
glucose
metabolism
in
liver
and
adipose
tissue.
Proc
Natl
Acad
Sci
U
S
A
100,
5419--5424.
46